Examining the Impact of Ertugliflozin on Cardiovascular Outcomes in Patients with Diabetes and Metabolic Syndrome: A Systematic Review of Clinical Trials

Cardiovascular diseases (CVDs) constitute a significant cause of morbidity and mortality globally, particularly among individuals with type 2 diabetes mellitus (T2DM). Ertugliflozin, a Sodium-Glucose Co-transporter-2 (SGLT2) inhibitor, is hypothesized to confer cardiovascular protection; however, lo...

Full description

Saved in:
Bibliographic Details
Main Authors: Silvius Alexandru Pescariu (Author), Ahmed Elagez (Author), Balaji Nallapati (Author), Felix Bratosin (Author), Adina Bucur (Author), Alina Negru (Author), Laura Gaita (Author), Ioana Mihaela Citu (Author), Zoran Laurentiu Popa (Author), Paula Irina Barata (Author)
Format: Book
Published: MDPI AG, 2024-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available